Systematic review, meta-analysis and economic modelling of ...

Appendix 8Lambda (λ), £ Prob NoT Prob ETT Prob HF Prob CTCA Prob CA135,000 0.1129 0 0.8620 0.0251 0140,000 0.0847 0 0.8820 0.0333 0145,000 0.0618 0 0.8938 0.0444 0150,000 0.0449 0 0.8943 0.0608 0155,000 0.0322 0 0.8919 0.0759 0160,000 0.0241 0 0.8808 0.0951 0165,000 0.0178 0 0.8678 0.1144 0170,000 0.0121 0 0.8564 0.1315 0175,000 0.0073 0 0.8388 0.1539 0180,000 0.0059 0 0.8198 0.1743 0185,000 0.0042 0 0.7989 0.1969 0190,000 0.0024 0 0.7763 0.2213 0195,000 0.0014 0 0.7550 0.2436 0200,000 0.0011 0 0.7337 0.2652 0205,000 0.0006 0 0.7106 0.2888 0210,000 0.0004 0 0.6879 0.3117 0215,000 0.0002 0 0.6630 0.3368 0220,000 0.0001 0 0.6401 0.3598 0225,000 0.0001 0 0.6203 0.3796 0230,000 0 0 0.5981 0.4019 0235,000 0 0 0.5775 0.4225 0240,000 0 0 0.5586 0.4414 0245,000 0 0 0.5411 0.4589 0250,000 0 0 0.5235 0.4765 0Prob CA, probability that invasive coronary angiography is cost-effective; Prob CTCA, probability that CT coronaryangiography is cost-effective; Prob ETT, probability that exercise tolerance testing is cost-effective; Prob HF, probabilitythat H-FABP is cost-effective; Prob NoT, probability that no testing or treatment is cost-effective.174NIHR Journals Library